Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database

OBJECTIVE: Three oral anticoagulants have reported study results for stroke prevention in patients with atrial fibrillation (AF) (dabigatran etexilate, rivaroxaban and apixaban); all demonstrated superiority or non-inferiority compared with warfarin (RE-LY, ARISTOTLE and ROCKET-AF). This study aimed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Sally, Monz, Brigitta U, Clemens, Andreas, Brueckmann, Martina, Lip, Gregory Y H
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2012
Assuntos:
Cardiovascular Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533028/
https://ncbi.nlm.nih.gov/pubmed/23242482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2012-001768
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados